The role of biologically active substances in gastroesophageal reflux disease in patients with type 2 diabetes mellitus
Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 2
Abstract
Background. The factors influencing the progression and clinical manifestations of gastroesophageal reflux disease (GERD) in patients with type 2 diabetes mellitus (DM) have not been sufficiently studied so far. To investigate the features of changes in serum prostaglandin (Pg) І2 and F2α levels depending on the clinical course of GERD in patients with type 2 DM was the purpose of our work. Materials and methods. The study involved 82 patients with GERD and type 2 DM (main, group 1) and comparison group (85 individuals, group 2). Serum levels of prostaglandin PgF2α and 6-keto-prostaglandin F1α (blood prostacyclin — PgI2) were evaluated in patients. Results. Digestive complaints characteristic of GERD have been detected in 61.0 % of persons from group 1, 22.0 % of individuals with combined pathology have been diagnosed with otolaryngologic form of GERD, and 17.1 % had a cardiac form. Patients with combined pathology have a more significant increase in the concentration of PgI2 with extra-esophageal manifestations of GERD, especially with its otolaryngologic form (4.1 times higher than indicators of the control group), whereas in patients with cardiac mask of GERD, its concentration is increased 3.5-fold, and in those with esophageal manifestations of GERD and type 2 DM — 3-fold. In patients with GERD, similar changes were detected 2.4 times (otolaryngologic manifestations), 2.2 times (cardiac manifestations) and 1.6 times (typical manifestations of GERD) more often. Conclusions. GERD in patients with type 2 DM is often manifested by extravascular symptoms (otolaryngologic, cardiac form). The maximum increase in the level of serum prostacyclin is established in patients with extraesophageal manifestations of GERD and type 2 DM, especially with its otolaryngologic form.
Authors and Affiliations
Ye. S. Sirchak, O. O. Boldizhar, M. P. Stan
Keywords
Related Articles
- EP ID EP290725
- DOI 10.22141/2308-2097.52.2.2018.132611
- Views 92
- Downloads 0
Surgical Correction of Structural and Functional Liver Diseases in Patients with Chronic Calculous Cholecystitis and Its Long-Term Results
During surgery for chronic calculous cholecystitis in 52 patients after the morphological confirmation of hepatic steatosis we have carried out surgical correction of structural and functional changes in the liver with p...
Pancreatic steatosis in children. Part 1. Etiology, epidemiology and pathogenesis
The article deals with the pancreatic steatosis (PS) in children — a pathological condition that is characterized by accumulation of fat in the pancreas. PS in patients with obesity and overweight in case of exclusion of...
Fibroscan and non-invasive indices for the diagnosis of nonalcoholic fatty liver disease
Background. Nonalcoholic fatty liver disease (NAFLD), an independent nosological entity, is characterized by fat accumulation in hepatocytes not associated with alcohol abuse, and includes a wide spectrum of disorders:...
Dysfunction of the biliary tract in children: traditional approaches and new postulates
Digestive system diseases take one of the leading places in the structure of somatic pathology of childhood. Functional disorders of the biliary tract is a set of clinical symptoms, which developed as a result of motor-t...
Current Options for Improvement of Treatment of Gastroesophageal Reflux Disease
The article is dedicated to the treatment of one of the most common pathologies in gastroenterology — gastroesophageal reflux disease. The use of proton pump inhibitors and their combination with prokinetics is being dwe...